HCoV-229E-IN-1
HCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively[1].
Product Specifications
CAS Number
[2639757-13-2]
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcov-229e-in-1.html
Purity
99.16
Solubility
DMSO : 12.5 mg/mL (ultrasonic)
Smiles
C=C([C@@H]1CC[C@@]2(CC[C@]3([C@@]4(CC[C@]5(C(C)(C6=C(C[C@@]5([C@]4(CC[C@@]3([C@]21[H])[H])[H])C)N=NN6[C@H](C7=CC=CC=C7)C)C)[H])C)C)C(O)=O)C
Molecular Formula
C38H53N3O2
Molecular Weight
583.85
References & Citations
[1]Stevaert A, et, al. Betulonic Acid Derivatives Interfering with Human Coronavirus 229E Replication via the nsp15 Endoribonuclease. J Med Chem. 2021 May 13;64 (9) :5632-5644.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
